End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
77,500 KRW | +2.38% |
|
+1.97% | -22.81% |
05-10 | SK Biopharmaceuticals Turns to Profit in Q1 as Sales Jump 88% | MT |
01-30 | SK Biopharmaceuticals Swings to Profit in Q4 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.81% | 4.4B | |
+7.39% | 72.09B | |
+15.93% | 9.05B | |
+17.59% | 4.39B | |
+25.93% | 3.94B | |
+4.64% | 2.1B | |
+9.09% | 1.97B | |
-36.86% | 1.87B | |
-0.50% | 1.64B | |
-48.24% | 1.61B |
- Stock Market
- Equities
- A326030 Stock
- News SK Biopharmaceuticals Co., Ltd.
- SK Biopharmaceuticals Enters Licensing Agreement with Hikma's Middle East Division